Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit

Sandaruwani Abeysiri; Toby Richards

doi:10.1016/j.eururo.2018.09.014

Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit

Sandaruwani Abeysiri, Toby Richards

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	e36
Number of pages	1
Journal	European Urology
Volume	75
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2018.09.014
Publication status	Published - Feb 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2018.09.014

Cite this

Abeysiri, S., & Richards, T. (2019). Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit. European Urology, 75(2), e36. https://doi.org/10.1016/j.eururo.2018.09.014

Abeysiri, Sandaruwani ; Richards, Toby. / Re : Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit. In: European Urology. 2019 ; Vol. 75, No. 2. pp. e36.

@article{5c520b3b90e3485fa3662e1d22950841,

title = "Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit",

author = "Sandaruwani Abeysiri and Toby Richards",

year = "2019",

month = feb,

doi = "10.1016/j.eururo.2018.09.014",

language = "English",

volume = "75",

pages = "e36",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier BV",

number = "2",

}

Abeysiri, S & Richards, T 2019, 'Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit', European Urology, vol. 75, no. 2, pp. e36. https://doi.org/10.1016/j.eururo.2018.09.014

Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit. / Abeysiri, Sandaruwani; Richards, Toby.
In: European Urology, Vol. 75, No. 2, 02.2019, p. e36.

Research output: Contribution to journal › Letter › Other › peer-review

TY - JOUR

T1 - Re

T2 - Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit

AU - Abeysiri, Sandaruwani

AU - Richards, Toby

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85059511114&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2018.09.014

DO - 10.1016/j.eururo.2018.09.014

M3 - Letter

C2 - 30268660

AN - SCOPUS:85059511114

SN - 0302-2838

VL - 75

SP - e36

JO - European Urology

JF - European Urology

IS - 2

ER -

Abeysiri S, Richards T. Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525–36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit. European Urology. 2019 Feb;75(2):e36. doi: 10.1016/j.eururo.2018.09.014

UN SDGs

Access to Document

Other files and links

Cite this